Thursday June 3, 2010

REVERSED

1600 Biotechnology and Organic Chemistry
Ex Parte Easterling et al 11/459,562 MILLS 103(a) FULBRIGHT & JAWORSKI L.L.P. EXAMINER HUANG, GIGI GEORGIANA

2100 Computer Architecture and Software
Ex Parte Lauzon et al 10/458,452 SIU 102(a) IBM CORP (YA) C/O YEE & ASSOCIATES PC EXAMINER DAO, THUY CHAN

2600 Communications
Ex Parte Schobben et al 10/548,242 NAPPI 103(a) PHILIPS INTELLECTUAL PROPERTY & STANDARDS EXAMINER ZUBAJLO, JENNIFER L

3700 Mechanical Engineering, Manufacturing, and Products & Design
Ex Parte Gesswein 10/394,630 STAICOVICI 112(2)/102(b) HOLLINGSWORTH & FUNK EXAMINER GRAY, PHILLIP A

AFFIRMED-IN-PART

1600 Biotechnology and Organic Chemistry
Ex Parte Benedict 10/916,108 GREEN 103(a) HOWREY LLP-HN EXAMINER PESELEV, ELLI

"The combination of familiar elements according to known methods is likely to be obvious when it does no more than yield predictable results." [KSR] at 416. Moreover, an "[e]xpress suggestion to substitute one equivalent for another need not be present to render such substitution obvious." In re Fout, 675 F.2d 297, 301 (CCPA 1982).

Fout, In re, 675 F.2d 297, 213 USPQ 532 (CCPA 1982). . . . . . . . . . . .2129, 2143.01, 2144.06

KSR International Co. v. Teleflex Inc., 550 USPQ2d 1385 (2007) . . . . . . . . .2141 to 2145, 2216, 2242, 2286, 2616, 2642, 2686.04

Ex Parte Campillo et al 11/218,295 LEBOVITZ 112(1)/102(b)/103(a) ELMORE PATENT LAW GROUP, PC EXAMINER ZHENG, LI

Consistent with Lilly and Amgen, in Enzo Biochem, Inc. v. Gen-Probe Inc., 323 F.3d 956, 964 (Fed. Cir. 2002), it was held that a claimed DNA could be described without, necessarily, disclosing its structure. The court adopted the standard that the written description requirement can be met by “show[ing] that an invention is complete by disclosure of sufficiently detailed, relevant identifying characteristics . . . i.e., complete or partial structure, other physical and/or chemical properties, functional characteristics when coupled with a known or disclosed correlation between function and structure, or some combination of such characteristics.” Id. at 964.

Enzo Biochem, Inc. v. Gen-Probe, Inc., 323 F.3d 956, 63 USPQ2d 1609 (Fed. Cir. 2002).. . . . . . . . . . . . . . . . . . . . . . . .2163

Ex Parte Shannon 11/179,813 LEBOVITZ 103(a) AGILENT TECHNOLOGIES INC. EXAMINER EPPS -SMITH, JANET L

Ex Parte Southern 10/772,467 PRATS 103(a) WENDEROTH, LIND & PONACK, L.L.P. EXAMINER SKIBINSKY, ANNA